Author： Samanta Johan Hauser Robert A
Publisher： Future Medicine
ISSN： 1745-509X
Source： Aging Health, Vol.2, Iss.2, 2006-04, pp. : 209-219
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
Rivastigmine for the treatment of Parkinson’s disease dementia
By Aarsland Dag Ehrt Uwe Gauthier Serge
Aging Health, Vol. 6, Iss. 3, 2010-06 ,pp. :
Access to resources
Recommend
Pramipexole in the management of Parkinson’’s disease
By Reichmann Heinz Michael Schüüpbach Werner Martin
Aging Health, Vol. 4, Iss. 3, 2008-06 ,pp. :
Transcranial sonography in Parkinson’’s disease
By ŠŠkoloudíík David Báártováá Petra Herzig Roman
Aging Health, Vol. 5, Iss. 1, 2009-02 ,pp. :
Tolcapone in the management of Parkinson’s disease
Aging Health, Vol. 2, Iss. 5, 2006-10 ,pp. :
Cognitive and psychiatric disturbances in Parkinson’’s disease
By Aarsland Dag Ehrt Uwe Rektorova Irena
Aging Health, Vol. 7, Iss. 1, 2011-02 ,pp. :